KL2

Medicine & Life Sciences

1. Adenocarcinoma 32%
2. African Americans 19%
3. Alleles 41%
4. Anus Neoplasms 29%
5. Arachis 26%
6. Asthma 22%
7. Autism Spectrum Disorder 18%
8. Biomarkers 19%
9. Bipolar Disorder 16%
10. Borderline Personality Disorder 28%
11. Brain 18%
12. Clopidogrel 21%
13. Cocaine 37%
14. Cohort Studies 33%
15. Communication 22%
16. Comorbidity 21%
17. Confidence Intervals 50%
18. Coronavirus 96%
19. Crohn Disease 50%
20. Cues 16%
21. Cytochrome P-450 CYP2C19 38%
22. Cytochrome P-450 CYP2C9 35%
23. Cytochrome P-450 CYP2D6 25%
24. Databases 19%
25. Drug Therapy 21%
26. Early Detection of Cancer 36%
27. Elderly 18%
28. Electronic Health Records 17%
29. Epidemiology 26%
30. Food Allergy Herbal Formula-2 29%
31. Gastro-enteropancreatic neuroendocrine tumor 39%
32. Genes 35%
33. Genetic Testing 19%
34. Genotype 31%
35. Guidelines 25%
36. Health 24%
37. Hepacivirus 49%
38. Hepatitis B 17%
39. Hepatitis C 41%
40. Hepatocellular Carcinoma 17%
41. Herbal Medicine 17%
42. Hispanic Americans 31%
43. HIV 68%
44. HIV-1 19%
45. Hospitalization 21%
46. Incidence 35%
47. Induced Pluripotent Stem Cells 16%
48. Infections 26%
49. Inflammation 22%
50. Inflammatory Bowel Diseases 100%
51. Liver 21%
52. Liver Transplantation 20%
53. Lung Neoplasms 65%
54. Magnetic Resonance Imaging 24%
55. Medicare 16%
56. Meningioma 18%
57. Meta-Analysis 24%
58. Methicillin-Resistant Staphylococcus aureus 18%
59. Mortality 30%
60. Mutation 45%
61. Neoplasms 78%
62. Neuroendocrine Tumors 66%
63. Non-Small Cell Lung Carcinoma 59%
64. Odds Ratio 32%
65. Oncologists 17%
66. Palliative Care 26%
67. Pancreatic Neoplasms 48%
68. Pandemics 29%
69. Patient Care Planning 25%
70. Peanut Hypersensitivity 22%
71. Personality Disorders 16%
72. Pharmaceutical Preparations 28%
73. Pharmacogenetics 86%
74. Pharmacogenomic Testing 26%
75. Phenotype 25%
76. phospholamban 19%
77. Population 44%
78. Positron-Emission Tomography 18%
79. Prefrontal Cortex 22%
80. Propensity Score 26%
81. Radiotherapy 16%
82. Registries 20%
83. Reward 16%
84. Safety 21%
85. SARS Virus 19%
86. Schizotypal Personality Disorder 28%
87. Severe Acute Respiratory Syndrome 23%
88. Squamous Intraepithelial Lesions 22%
89. Substance-Related Disorders 21%
90. Suicide 28%
91. Survival 48%
92. Systematic Reviews 18%
93. Therapeutics 63%
94. Transplant Recipients 18%
95. Tumor Necrosis Factor Inhibitors 18%
96. Ulcerative Colitis 56%
97. vedolizumab 43%
98. Veterans 26%
99. Virus Diseases 17%
100. Warfarin 24%